Notice: You have clicked on a link which leaves Fresenius Kabi’s website and you will be redirected to a third-party website. Fresenius Kabi makes no representations nor has any supervision or control over the quality, content, reliability, or security of the third-party website, nor shall Fresenius Kabi be liable for its use.

Logotype: Fresenius Kabi USA - Nutrition

Innovations that nourish

As pioneers in clinical nutrition, our innovations nourish at every age and stage of life. Our parenteral nutrition (PN) products are used to help care for critically ill and chronically ill patients in hospitals, long-term care facilities, and at home. We’re proud to be the U.S. market leader in lipid injectable emulsions (ILEs).1

Get the full story


Caring for the COVID-19 patient

Optimal nutritional support is critical for COVID-19 patients in the ICU, which is why experts recommend considering alternative ILEs for this patient population.2 As an early pioneer in alternative mixed lipid emulsions, Fresenius Kabi is expanding clinical nutrition options for critically ill patients.

The role of alternative ILEs

As part of our dedication to developing alternative ILEs, we introduced omega-3-containing fish oil into our PN products, which may have less pro-inflammatory effects.3

At the forefront of PN

A tireless dedication to driving advancements in lifesaving medicines and technologies has led to many firsts in the field, like introducing the first lipid PN product for adults in more than 40 years, keeping Fresenius Kabi at the forefront of PN.

  • 2014
    Developed the first and only three-chamber bag for adult PN in the U.S.

  • 2016
    Pioneered the use of fish oil and omega-3s in PN products

  • 2016
    Brought the benefits of alternative lipid emulsions to market

  • 2018
    Developed the only pediatric lipid ILE product for PN-associated cholestasis (PNAC) in the U.S.

  • 2022
    The first four-oil ILE product approved for pediatric patients including term and preterm neonates

  • 2022 and beyond
    Pipeline products

Meet the experts in PN

Are you hungry for fish oil facts or thirsting for knowledge on omega-3s in PN? Tune in to audio recordings featuring experts in the field.

Innovative PN products

Lipid source matters. Learn about Fresenius Kabi’s introduction of alternative oil sources in PN.

Application portal for Investigator Initiated Trials

Fresenius Kabi is welcoming healthcare professionals and researchers to submit study proposals and apply for investigator-initiated trial sponsorship.

KabiCare Patient Support Program for Nutrition

Fresenius Kabi offers an industry standard patient support program, KabiCare. Claims appeals and billing and coding online resources for Parenteral Nutrition are available for your eligible patients.

If you still can't find what you're looking for regarding our PN products or Fresenius Kabi Nutrition, let us know and we can help.

Contact us

References: 1. Data on File; 6/1/22; calculation includes: all ILEs approved in the US. 2. Martindale R, Patel JJ, Taylor B, et al. Nutrition therapy in critically ill patients with coronavirus disease 2019. JPEN J Parenter Enteral Nutr. 2020;44(7):1174-1184. 3. Vanek VW, Seidner DL, Allen P, et al. Novel Nutrient Task Force, Intravenous Fat Emulsions Workgroup; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012;27(2):150-192. doi:10.1177/0884533612439896